Sodium lauryl sulfate in shampoo and the cancer claim

This page is for anyone who has seen a warning that a shampoo ingredient causes cancer. It explains what FDA actually says.

The forwarded warning about foaming shampoo ingredients has been going around since the days of chain emails. It usually names sodium lauryl sulfate, calls it an industrial degreaser, and says it causes cancer.

FDA's 1,4-dioxane page does not name that foaming agent as a carcinogen. What FDA does publish about this product type is something different, and more specific: a manufacturing byproduct called 1,4-dioxane.

Understanding that swap is the whole point of this page. The claim is pointing at the wrong molecule.

Nobody adds 1,4-dioxane to anything on purpose. It forms during the making of certain cosmetic ingredients. The process is called ethoxylation, and it makes harsh cleansers gentler.

FDA points to markers you can actually spot on a label. Ingredients with names that include PEG, Polyethylene, or an -eth- part have gone through that process. Notably, FDA's page does not name sodium lauryl sulfate itself at all.

FDA calls 1,4-dioxane a potential human carcinogen. The National Toxicology Program says it is reasonably anticipated to be a human carcinogen, and that call is based on animal studies. Human data are called inadequate.

"Reasonably anticipated" is a real classification with real weight. It is deliberately not the same thing as "known to cause cancer in people."

This is one of the few consumer-product stories with a clear downward trend you can point to. FDA has tested cosmetics for this byproduct since 1981.

• 1981 tests averaged 50 ppm (parts per million).
• 1997 tests averaged 19 ppm.
• In the 2008 survey, 80 percent of products had no detectable amount, and the highest single result was 11.6 ppm.
• In a 2018 survey of children's products, only 2 percent went above 10 ppm.

The reason those numbers fell is not a mystery. Since the 1980s, FDA has told manufacturers to use a step called vacuum stripping to pull the byproduct out during production. The industry took up the practice.

FDA's page does not give shoppers instructions, and it would be wrong for us to invent any. What we can say is what the record shows. This is a contamination issue that regulators found and told manufacturers how to fix. They then tracked the levels as they dropped over four decades.

If you would rather avoid ethoxylated ingredients, the label markers above let you do that. If you do not want to think about it at all, the survey trend is useful context to keep in mind.

Ingredient scares travel well because they offer something rare: a specific villain, and a simple fix. Stop using this shampoo, and you feel like you have done something.

Real cancer prevention is less satisfying that way. It is built from habits and screening, not swapped-out bottles. That does not make ingredient questions silly, and regulators do not ignore them either. It just means the honest answer to "is my shampoo giving me cancer" is usually a careful no, plus a more interesting story about how manufacturing gets cleaned up over time.

If you are going through cancer treatment right now, worrying about your shampoo is understandable. But it is rarely where your attention is best spent. Screening, treatment, and the habits with solid evidence behind them will matter far more to your outcome than which bottle sits on your shower shelf. If a specific ingredient claim is weighing on you, it is a completely fair thing to raise with your care team, if only to put your mind at ease and move on.